JP2008534672A5 - - Google Patents

Download PDF

Info

Publication number
JP2008534672A5
JP2008534672A5 JP2008504870A JP2008504870A JP2008534672A5 JP 2008534672 A5 JP2008534672 A5 JP 2008534672A5 JP 2008504870 A JP2008504870 A JP 2008504870A JP 2008504870 A JP2008504870 A JP 2008504870A JP 2008534672 A5 JP2008534672 A5 JP 2008534672A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
pharmaceutical composition
compound
acceptable salt
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008504870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008534672A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/000954 external-priority patent/WO2006106427A1/en
Publication of JP2008534672A publication Critical patent/JP2008534672A/ja
Publication of JP2008534672A5 publication Critical patent/JP2008534672A5/ja
Withdrawn legal-status Critical Current

Links

JP2008504870A 2005-04-06 2006-03-27 抗菌剤としての7−フルオロ−1,3−ジヒドロ−インドール−2−オンオキサゾリジノン Withdrawn JP2008534672A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66871505P 2005-04-06 2005-04-06
US68403305P 2005-05-24 2005-05-24
PCT/IB2006/000954 WO2006106427A1 (en) 2005-04-06 2006-03-27 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008534672A JP2008534672A (ja) 2008-08-28
JP2008534672A5 true JP2008534672A5 (cg-RX-API-DMAC10.html) 2009-05-14

Family

ID=36636389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504870A Withdrawn JP2008534672A (ja) 2005-04-06 2006-03-27 抗菌剤としての7−フルオロ−1,3−ジヒドロ−インドール−2−オンオキサゾリジノン

Country Status (21)

Country Link
US (1) US7435751B2 (cg-RX-API-DMAC10.html)
EP (1) EP1869030A1 (cg-RX-API-DMAC10.html)
JP (1) JP2008534672A (cg-RX-API-DMAC10.html)
KR (1) KR20070108938A (cg-RX-API-DMAC10.html)
AP (1) AP2007004172A0 (cg-RX-API-DMAC10.html)
AR (1) AR053839A1 (cg-RX-API-DMAC10.html)
AU (1) AU2006231919A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0610533A2 (cg-RX-API-DMAC10.html)
CA (1) CA2603899A1 (cg-RX-API-DMAC10.html)
CR (1) CR9417A (cg-RX-API-DMAC10.html)
DO (1) DOP2006000080A (cg-RX-API-DMAC10.html)
GT (1) GT200600133A (cg-RX-API-DMAC10.html)
IL (1) IL186119A0 (cg-RX-API-DMAC10.html)
MX (1) MX2007012386A (cg-RX-API-DMAC10.html)
NL (1) NL1031525C2 (cg-RX-API-DMAC10.html)
NO (1) NO20075505L (cg-RX-API-DMAC10.html)
PE (1) PE20061301A1 (cg-RX-API-DMAC10.html)
TN (1) TNSN07373A1 (cg-RX-API-DMAC10.html)
TW (1) TW200716101A (cg-RX-API-DMAC10.html)
UY (1) UY29452A1 (cg-RX-API-DMAC10.html)
WO (1) WO2006106427A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
KR100891485B1 (ko) 2007-10-29 2009-04-02 주식회사 만도 디스크 브레이크의 주차브레이크 장치
US20090124737A1 (en) * 2007-11-12 2009-05-14 Eastman Chemical Company Acrylic plastisol viscosity reducers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157934T3 (es) 1988-09-15 2001-09-01 Upjohn Co Fenil-5-beta-amidometiloxazolidin-2-onas sustituidas con nitrogeno en la posicion 3.
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
DE4425613A1 (de) 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
DE19649095A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue Heteroaryl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
CA2318969A1 (en) 1998-01-23 1999-07-29 Mikhail F. Gordeev Oxazolidinone combinatorial libraries, compositions and methods of preparation
DE69912264T2 (de) 1998-04-14 2004-07-22 Samsung Fine Chemicals Co., Ltd. Verfahren zur herstellung chiraler (s)-2,3-disubstituierter 1-propylamin-derivate
AU1379900A (en) 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel substituted phenyloxazolidone derivatives
WO2000032599A1 (en) 1998-11-27 2000-06-08 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
EP1181288B1 (en) 1999-05-27 2003-07-30 PHARMACIA & UPJOHN COMPANY Bicyclic oxazolidinones as antibacterial agent
ATE321024T1 (de) 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
DE60212959T2 (de) 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
ATE374463T1 (de) 2001-04-20 2007-10-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonen
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents

Similar Documents

Publication Publication Date Title
JP2009526832A5 (cg-RX-API-DMAC10.html)
CN1068328C (zh) 螺环和双环二嗪基和咔嗪基噁唑烷酮类
ES2287354T3 (es) Antibioticos de accion dual.
Selvakumar et al. Synthesis of conformationally constrained analogues of linezolid: structure− activity relationship (SAR) studies on selected Novel tricyclic oxazolidinones
US20010047004A1 (en) Oxazolidinone thioamides with piperazine amide substituents
JP4607107B2 (ja) シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体
ES2437575T3 (es) Derivados de quinolina como agentes antibacterianos
JP2009503024A5 (cg-RX-API-DMAC10.html)
AU739055B2 (en) Oxazolidinone derivatives and pharmaceutical compositions
HUP0203869A2 (hu) Szulfoximin funkcionalitással rendelkező oxazolidinok és alkalmazásuk mikrobaellenes szerként, a vegyületeket tartalmazó gyógyszerkészítmények
RU2013137752A (ru) Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины
BRPI0614493A2 (pt) uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto, processo para a preparação de um composto e o referido composto
CN102164919B (zh) 噁唑烷基抗生素
US6642238B2 (en) Oxazolidinone thioamides with piperazine amide substituents
JP2009503025A5 (cg-RX-API-DMAC10.html)
WO2012114355A1 (en) Novel process for preparation of linezolid and its novel intermediates
US20060229316A1 (en) Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
US8507540B2 (en) Oxazolidinone derivatives containing new bicyclic group, having antibacterial activity, and method for treating pathogenic bacterial infections using the same
JP2008544979A5 (cg-RX-API-DMAC10.html)
MX2011005365A (es) Antimicrobianos novedosos.
JP2009526036A5 (cg-RX-API-DMAC10.html)
JP2009525318A5 (cg-RX-API-DMAC10.html)
CN101619061A (zh) 氰基吡啶基取代的噁唑烷酮类化合物
Graul et al. T-3811ME
US20060020004A1 (en) Isoxazolidine compounds for treatment of bacterial infections